Early diagnosis, better prognosis. We are Reccan, a young medtech company dedicated to improving the prognosis for patients diagnosed with pancreatic cancer. Our vision is to set a standard for early detection of pancreatic cancer and therefore save lives. We are working to change the trajectory of pancreatic cancer mortality by finding the cancer at an earlier stage than is possible today. Early detection makes interventions and treatments more effective.
| Website | https://www.reccandiagnostics.com/ |
| Revenue | $1 million |
| Employees | 4 (2 on RocketReach) |
| Founded | 2014 |
| Address | 12 Karlavägen, Lund, Skane, SE |
| Phone | +46 70 663 00 00 |
| Industry | Biotechnology Research, Manufacturing General, Manufacturing |
| Keywords | Early Cancer Detection, Medical Diagnostic Technology, Oncology Diagnostics, Liquid Biopsy, Medical Devices, Cancer Testing, Diagnostic Testing, Healthcare Technology, Medical Technology, Health Diagnostics, Biotechnology, Early Disease Detection, Medical Research, Cancer Research |
| Competitors | Siemens, Roche, Thermo Fisher Scientific, Abbott, BD, Cepheid, PerkinElmer, Inc., Bio-Rad Laboratories, QIAGEN +32 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 325413 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular Reccan Diagnostics employee's phone or email?
The Reccan Diagnostics annual revenue was $1 million in 2026.
Anna Broden is the CEO of Reccan Diagnostics.
2 people are employed at Reccan Diagnostics.
Reccan Diagnostics is based in Lund, Skane.
The NAICS codes for Reccan Diagnostics are [32541, 325, 325413, 32, 3254].
The SIC codes for Reccan Diagnostics are [283, 28].